Literature DB >> 26362859

iNOS affects matrix production in distal lung fibroblasts from patients with mild asthma.

Anna-Karin Larsson-Callerfelt1, Maria Weitoft2, Kristian Nihlberg3, Leif Bjermer4, Gunilla Westergren-Thorsson5, Ellen Tufvesson6.   

Abstract

INTRODUCTION: A high level of exhaled nitric oxide (NO) is a marker for inflammation in the airways of asthmatic subjects. However, little is known about how NO and inducible nitric oxides synthase (iNOS) activity may affect remodelling in the distal lung. We hypothesized that there is a link between iNOS and ongoing remodelling processes in the distal lung of mild asthmatics.
METHODS: Patients with mild asthma (n = 6) and healthy control subjects (n = 8) were included. Exhaled NO was measured at different flow rates and alveolar NO concentrations were calculated. For studies of remodelling processes in the distal lung, primary fibroblasts were grown from transbronchial biopsies and stimulated with unselective and selective NOS inhibitors or a NO donor. The mRNA expression of iNOS and synthesis of NO (indirectly as nitrite/nitrate) were measured and distal lung fibroblast synthesis of the extracellular matrix proteoglycans were analysed.
RESULTS: The distal lung fibroblasts expressed iNOS, and there was a tendency of higher expression in fibroblasts from patients with asthma. The selective iNOS inhibitor 1400 W inhibited iNOS expression and NO synthesis in fibroblasts from patients with asthma (p = 0.031). Treatment with 1400 W significantly increased synthesis of the proteoglycan versican (p = 0.018) in distal fibroblasts from patients with asthma whereas there were no effects in fibroblasts from control subjects.
CONCLUSIONS: Our data suggest that there is a link between iNOS and remodelling in the distal lung of subjects with mild asthma and that iNOS could have a modulatory role in pathological airway remodelling.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asthma; Inducible nitric oxide synthase; Lung fibroblast; Proteoglycan; Remodelling

Mesh:

Substances:

Year:  2015        PMID: 26362859     DOI: 10.1016/j.pupt.2015.09.003

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


  2 in total

1.  Myeloid-derived suppressor cells (MDSCs) and mechanistic target of rapamycin (mTOR) signaling pathway interact through inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in asthma.

Authors:  Yanli Zhang; Boyi Xu; Bin Luan; Yan Zhang; Yanling Li; Xiaorong Xiong; Hongke Shi
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  The Reliability of Adjusting Stepped Care Based on FeNO Monitoring for Patients with Chronic Persistent Asthma.

Authors:  Xiaoru Wang; Ling Wu; Zhi Zhang; Qinghua Kong; Hui Qi; Han Lei
Journal:  Open Med (Wars)       Date:  2019-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.